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primary importance for toxicological studies. Expression of 
various of these genes (e.g., GSTA1, ADH1C, ALDH1A1, 
CYP2B6, CYP2F1, CYP4B1, CYP4X1 and CYP4Z1) was 
elevated following the mucociliary differentiation of air-
way epithelial cells into a pseudo-stratified epithelial layer. 
Although a substantial number of genes were differentially 
expressed between donors, the differences in fold changes 
were generally small. Metabolic activity measurements 
applying a variety of different cytochrome p450 substrates 
indicated that epithelial cultures at the early stages of dif-
ferentiation are incapable of biotransformation. In contrast, 
mature ALI-PBEC cultures were proficient in the metabolic 
conversion of a variety of substrates albeit with consider-
able variation between donors. In summary, our data indi-
cate a distinct increase in biotransformation capacity during 
differentiation of PBECs at the air–liquid interface and that 
the generation of biotransformation competent ALI-PBEC 
Abstract Differentiated human bronchial epithelial cells 
in air liquid interface cultures (ALI-PBEC) represent a 
promising alternative for inhalation studies with rodents 
as these 3D airway epithelial tissue cultures recapitulate 
the human airway in multiple aspects, including morphol-
ogy, cell type composition, gene expression and xenobi-
otic metabolism. We performed a detailed longitudinal 
gene expression analysis during the differentiation of sub-
merged primary human bronchial epithelial cells into ALI-
PBEC to assess the reproducibility and inter-individual 
variability of changes in transcriptional activity during 
this process. We generated ALI-PBEC cultures from four 
donors and focussed our analysis on the expression levels 
of 362 genes involved in biotransformation, which are of 
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cultures is a reproducible process with little variability 
between cultures derived from four different donors.
Keywords Lung · Metabolic activity · Gene expression 
profiling · Bronchial epithelial cells · Cytochrome P450
Introduction
Inhalation represents one of the major routes by which 
humans are exposed to gases, volatile compounds, aerosols 
and respirable particles. After entrance into the respiratory 
tract, inhaled materials may be absorbed by pulmonary 
cells and surrounding tissues. Cells of the respiratory tract 
have been shown to be metabolically competent and able 
to biotransform a large variety of inhaled substances (Ant-
tila et al. 2011; Hukkanen et al. 2002; Zhang et al. 2006). 
These biotransformation reactions enable detoxification of 
xenobiotics and facilitate elimination of hazardous com-
pounds from the body (Nebert and Dalton 2006). However, 
in some cases biotransformation results in the formation of 
highly reactive intermediates that can bind to various bio-
molecules including DNA. A classic example is the acti-
vation of benzo(a)pyrene, a constituent of tobacco smoke 
and combustion products, into reactive species leading to 
the formation of mutagenic DNA adducts that have been 
implicated in the development of cancer (Denissenko et al. 
1996).
Assessment of the potential cancer risk of substances 
for man is still largely based on data obtained from studies 
with laboratory animals. While extensive toxicological data 
have been generated using in vivo animal models exposed 
via oral or dermal administration, the amount of data 
obtained using inhalation as an exposure route is far more 
limited. The high workload, the requirement of specialized 
equipment and knowledge, and high costs are among the 
main practical barriers for inhalation studies. Additionally, 
extrapolation of lung cancer data obtained with experimen-
tal animals to humans is inherently difficult and not only 
because of physiological differences. Various carcinogenic 
airborne substances show species-dependent differences 
with regard to their potential to induce tumors that for a 
significant part can be attributed to species-related differ-
ences in biotransforming capacity within the lung (Bond 
and Medinsky 2001; Cruzan et al. 2009). These observa-
tions raise concerns about the suitability of animal expo-
sures for health risk prediction of airborne substance in 
humans.
The development of sophisticated in vitro models based 
on cells from human pulmonary origin might contribute to 
a better understanding of the basis of human lung toxic-
ity and might ultimately form an alternative for inhalation 
studies with laboratory animals. In recent years, protocols 
have been established for the generation of air–liquid inter-
face (ALI) cultures of well-differentiated airway epithelial 
cells containing various cell-types including club (formerly 
called Clara cells), ciliated and goblet cells. The air-exposed 
nature of these cultures makes them promising vehicles 
for toxicity studies of airborne substances (Iskandar et al. 
2015; Kogel et al. 2015; Mathis et al. 2013; Neilson et al. 
2015). Even chronic long-term or repeated exposures, to 
better mimic human occupational exposures, are realis-
tic possibilities (Talikka et al. 2014). Furthermore, use of 
cells from designated patient populations or exposure of 
the cells during differentiation to disease-specific factors, 
such as Th2 cytokines for allergic airways inflammation, 
can be used to generate disease-specific models. Toxicity 
can be assessed applying conventional cytotoxic end points 
such as the inhibition of cell proliferation and the induction 
of cell death, as well as on the tissue level by monitoring 
changes in its composition, ciliary beating frequency and 
barrier function [e.g., changes in transepithelial electri-
cal resistance (TEER)] (Kuehn et al. 2015). For these pur-
poses, it is important that these ALI cultures mimic human 
lung epithelium in their ability to biotransform xenobiotic 
chemicals which is supported by the presence of differenti-
ated cell types such as club cells that have been implicated 
in biotransformation processes in the lung (Chichester 
et al. 1991; Hukkanen et al. 2002). Transcriptome analy-
ses showed that these organotypic cultures recapitulate the 
transcriptional profile of in vivo airway epithelia (Dvorak 
et al. 2011; Pezzulo et al. 2011) while metabolic activity of 
for instance CYP1A1/1B1 and CYP2A6/2A13 is conserved 
(Baxter et al. 2015; Newland et al. 2011). In this study, we 
aimed to get a better insight into the temporal changes in 
gene activity during the differentiation of submerged pri-
mary human bronchial epithelial cells into ALI-PBEC and 
to assess the reproducibility and inter-individual variability 
of changes in transcriptional activity during this process. 
Focusing on a comprehensive list of genes relevant for bio-
transformation processes including Phase I and II enzymes, 
transporter genes and nuclear receptors, we addressed the 
reproducibility and inter-individual variability of expres-
sion of these genes and determined the ability of these cul-
tures to metabolize a variety of xenobiotic compounds.
Materials and methods
Cell culture
Primary human bronchial epithelial cells were isolated 
from tumor-free resected lung tissue from four anonymous 
donors by enzymatic digestion essentially as described 
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previously (van Wetering et al. 2000). Cells were expanded 
in keratinocyte serum-free medium (KSFM, Gibco) by 
sub-culturing until passage 3, and aliquots were stored in 
liquid nitrogen. ALI-PBEC were generated essentially as 
previously described (Amatngalim et al. 2015; van Weter-
ing et al. 2007). In brief, cells were brought into culture 
and after the next passage they were collected and seeded 
in transwell tissue culture inserts (Corning Costar) with 
a pore size of 0.4 µm and a surface of 1.12 cm2. Tran-
swells were coated with a mixture of 30 mg/ml PureCol 
(Advanced BioMatrix, San Diego, CA), 10 μg/ml BSA 
(Sigma-Aldrich, St. Louis, MO) and 10 μg/ml fibronectin 
(isolated from human plasma) diluted in PBS, at 37 °C, 
5 % CO2 for 2–24 h. Initially, cultures were grown under 
submerged conditions using a 1:1 mixture of DMEM (Life 
Technologies, Bleiswijk, the Netherlands) and bronchial 
epithelial growth medium (Lonza, Verviers, Belgium) 
(B/D medium) with supplementation of BEGM BulletKit 
singlequots (0.4 % [w/v] bovine pituitary extract, 1 mM 
hydrocortisone, 0.5 μg/ml human hEGF, 0.5 μg/ml epi-
nephrine, 10 μg/ml transferrin, 5 μg/ml insulin, T3 and 
0.1 ng/ml retinoic acid) (Lonza) and additional 1 mM 
HEPES (Lonza), 1 μg/ml BSA (Sigma-Aldrich), 100 U/ml 
penicillin and 100 μg/ml streptomycin (Lonza) and 15 ng/
ml retinoic acid (Sigma-Aldrich). After around 6 days, 
the medium above the confluent cell layer was removed. 
Air-exposed cultures were maintained for up to 28 days 
with growth medium replacement every 2–3 days fol-
lowing an apical wash with 100 µl PBS to remove excess 
mucus. Mucociliary differentiation was typically observed 
between day 7 and 11 independent of the donor. Differen-
tiated cell cultures expressed markers of basal, ciliated and 
goblet cells (Amatngalim et al. 2015; Mertens et al. 2016). 
Club cells were present in very low amounts as shown by 
expression of SCGB1A1 (unpublished observation). All 
cultures were maintained at 37 °C in a humidified atmos-
phere of 5 % CO2.
Chemical exposure of ALI‑PBEC cultures
Mature ALI-PBEC cultures, maintained at the air–liquid 
interface for 15 days, were exposed to 20 µM benzo[a]
pyrene (B[a]P), 125 µM dibenzo(a,h)anthracene (DBA) or 
50 nM 2,3,7,8,-tetrachlorodibenzo-para-dioxin (TCDD) 
for 24 or 72 h in comparison with time-matched sol-
vent (DMSO) controls. All chemicals were obtained from 
Sigma-Aldrich, and the final DMSO concentration was 
0.5 % (v/v) for all exposed cultures. Directly after expo-
sure, RNA was isolated as described below. Measurement 
of trans-epithelial electrical resistance (TEER), a marker 
for epithelial layer disruption, using the Millicell ERS-2 
(Millipore), was used to assess toxicity induced after 24-h 
exposure to 2 µM aflatoxin B1 with and without 72 h pre-
treatment to 100 nM TCDD.
RNA isolation and microarray hybridization
Microarray analysis was performed on passage 4 primary 
bronchial epithelial cells grown under various conditions 
ranging from undifferentiated cells grown under submerged 
conditions to differentiated cells in air-exposed cultures. 
Total RNA was extracted using TRIzol (Life Technologies) 
according to the manufacturer’s instructions and purified 
using RNeasy mini kits (Qiagen). RNA purification and 
quality were assessed using the Agilent 2100 bioanalyzer 
to determine the 28S:18S rRNA ratio. Sample prepara-
tion, hybridization, washing, staining and scanning of the 
Affymetrix Human Genome U133 Plus 2.0 GeneChip 
arrays were performed as previously described (Jennen 
et al. 2010). The microarray data are available through the 
diXa data warehouse (Hendrickx et al. 2015) under study 
ID DIXA-004 (sample names starting with LUM-1; B[a]P, 
LUM-2; differentiation, LUM-4; DBA and TCDD) (http://
wwwdev.ebi.ac.uk/fg/dixa/group/DIXA-004).
Microarray data analysis
After a quality assessment step, expression values were 
normalized by GeneChip robust multi-array average (GC-
RMA) and further analyzed with Genedata Expression-
ist 6.2 and GeneSpring (GX 10.0.1), respectively. In this 
study, we restricted the analysis to a comprehensive list of 
genes involved in xenobiotic metabolism. As starting point, 
the complete list of (Leclerc et al. 2011) was used supple-
mented with additional genes from the gene ontology terms 
0006805 ‘xenobiotic metabolic process’ and 0017144 
‘Drug metabolic process’ and the KEGG maps 00980 
‘Metabolism of xenobiotics by cytochrome p450’ and 
00982 ‘drug metabolism—cytochrome p450.’ The genes 
on the compiled list are represented by 779 probe sets 
present on the applied Affymetrix U133 Plus 2.0 microar-
rays. Probe sets annotated as ‘_x_at’ were excluded from 
the analysis as they contain probes that are identical or 
highly similar to unrelated sequences. In total, 679 probe 
sets were considered representing a total of 362 genes. The 
genes were subdivided into the same 5 categories as done 
by (Leclerc et al. 2011), namely Phase I enzymes, Phase 
II enzymes, transporter genes, nuclear receptor genes and 
a set of other genes. The distribution of the genes over the 
categories is shown in Table 1. For a complete list of genes 
and probe sets see Supplementary Table S1.
To identify differentially regulated genes for each cul-
ture condition, paired ANOVA analysis with donors as 
pairing variable and a fold-change threshold of ≥2 for the 
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group medians was performed. The Benjamini–Hochberg 
(BH) procedure was applied to p values for multiple testing 
correction (Benjamini and Hochberg 1995). This procedure 
resulted in the identification of 143 genes (BH-corrected q 
values ≤0.05) from which the expression was significantly 
altered during the process of differentiation (Table 1).
Evaluation of P450 activities
The basal activities of cytochrome p450 s were determined 
with a cocktail of eight substrates as described previously 
(Lahoz et al. 2008). The substrate mixture stock solutions 
was prepared in DMSO and diluted in growth medium to 
obtain the following final concentrations: 10 µM phenace-
tin (CYP1A2), 5 µM coumarin (CYP2A6), 10 µM bupro-
pion (CYP2B6), 10 µM diclofenac (CYP2C9), 50 µM 
mephenytoin (CYP2C19), 10 µM bufuralol (CYP2D6), 
50 µM chlorzoxazone (CYP2E1) and 5 µM midazolam 
(CYP3A4). The final concentration of DMSO during incu-
bation was 0.5 % (v/v). ALI-PBEC were exposed for 5 h 
to the substrate cocktail in 1 ml medium. Exposure was 
either from below the insert (basal side), from inside the 
insert (apical side) or at both sides of the insert. ALI-PBEC 
cultures contain between 0.6 and 0.8 × 106 cells. A similar 
number of undifferentiated submerged growing cells were 
incubated with the substrate cocktail. At the end of the 
incubation time, aliquots of the media were collected and 
stored at −80 °C until delivery and analysis at Analytical 
Unit at IIS-La Fe (Valencia, Spain). Samples were analyzed 
as described previously (Lahoz et al. 2008). For each con-
dition, two independent ALI-PBEC cultures were used for 
the analysis. Enzymatic activities were expressed as pico-
mole of metabolites formed per tissue culture per hour.
The induced activity of CYP1A1 and CYP1B1 after 
exposure to TCDD was accessed using the P450-Glo 
CYP1A1 assay kit (Promega) containing luciferin-CEE, 
a typical substrate for both CYP1A1 and CYP1B1 (for 
details see documentation at the Promega website). The 
assay was performed according to the guidelines of the 
manufacturer.
Results
Influence of differentiation on the expression of genes 
involved in biotransformation
ALI-PBEC were generated from primary bronchial epithe-
lial cells derived from four donors. To study the influence 
of culture conditions and differentiation on the transcrip-
tion of genes involved in xenobiotic metabolic processes, 
RNA samples were collected at various time points during 
the establishment of the differentiated airway epithelial 
cultures. More specifically, RNA was isolated from sub-
confluent cells grown on petri dishes under submerged 
conditions in KSFM medium, from cells grown to a con-
fluent epithelial layer on tissue culture inserts in growth 
medium, just before (day 0) or at various days (4, 7, 11, 
14, 21 and 28) after initiation of air exposure during which 
the cell layer gradually differentiated into mucociliary 
epithelium. Subsequently, RNA samples were used for 
gene expression analysis using Affymetrix U133 Plus 2.0 
microarrays. We restricted our analysis to a subset of 362 
genes encoding Phase I and Phase II enzymes, transporter 
and receptors (Table 1, Supplementary Table S1). Paired 
ANOVA analysis with donors as pairing variable and a 
fold-change threshold of ≥2 for the group medians iden-
tified the expression of 143 genes (BH-corrected q values 
≤0.05) to be significantly altered during the process of dif-
ferentiation (Table 1; Fig. 1a). The most dramatic change in 
gene expression was observed when cells were shifted from 
sub-confluent growth on plastic in KFSM medium to sub-
merged growth on tissue culture inserts as a confluent layer 
of cells in B/D medium (Supplementary Fig. S1). seven 
days after culturing at the air–liquid interface, the expres-
sion level of most of the genes involved in biotransforma-
tion had stabilized. Comparing gene expression profiles at 
the starting condition (cells grown in KSFM) with that of 
ALI-PBEC after 28 days of air-exposed culturing, identi-
fied the Phase I enzymes ADH1C, ALDH1A1, CYP2B6, 
CYP2F1, CYP4B1 and CYP4X1 (Fig. 1b), and the Phase 
II enzyme GSTA1 (Supplementary Fig. S2) as being the 
Table 1  Differentially 
expressed genes per category of 
biotransformation
BH q value ≤0.05 and FC ≥ 2
Category Number of genes Number of genes with 
altered expression
Percentage of genes with 
altered expression (%)
Phase I enzymes 128 62 48.4
Phase II enzymes 52 25 48.1
Transporter 104 32 30.8
Receptor 48 14 29.2
Other 30 10 33.3
Total 362 143 39.5
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most up-regulated genes (median FC > 100). Strong down-
regulated genes (median FC > 10) included the trans-
porter genes SLC7A5, SLC7A11 and SLC22A3, and the 
nuclear receptor FOXA2. The genes encoding CYP1B1 
and CYP51A1 were most highly expressed with changes in 
gene expression being less than twofold between any two 
culture conditions.
Correlation between expression and activity of CYP450
We noticed a clear enhanced expression of a large fraction 
of the genes involved in xenobiotic metabolism during the 
differentiation procedure (Fig. 1, Supplementary Fig. S2). 
To demonstrate that this increased expression resulted in 


































































Fig. 1  a 2D hierarchical clustering of the expression levels of the 
143 differentially expressed genes. Columns are grouped according to 
the sampling time point. On day 0, the cells were still growing sub-
merged either sub-confluent in KSFM medium or confluent in B/D 
medium. The other time points represent the duration of air-exposed 
culturing. The four columns per sampling time point represent the 
individual expression values for the four donors (from left to right; 
BR200, BR234, BR259 and BR265). b Tile plot of the expression 
levels of genes encoding Phase I enzymes in alphabetical order. The 
most up-regulated genes (medium FC > 100) are marked in red, and 
the genes with a relatively high basal expression independent of the 
culture conditions (medium FC < 2) are marked in green. See Sup-
plementary Fig. S1 for the other gene categories (color figure online)
2098 Arch Toxicol (2017) 91:2093–2105
1 3
activity of several CYP450 s. For the first series of experi-
ments, cells derived from four different donors were either 
grown under undifferentiated submerged conditions or were 
allowed to differentiate into ALI-PBEC for 14 days. These 
cultures were subsequently incubated with the substrate 
mixture either at the basal side, the apical side or at both 
sides to determine the most suitable exposure route. Metab-
olites present in medium samples of the various cultures 
were quantified for a cocktail of substrates by liquid chro-
matography tandem mass spectrometry. Metabolites typical 
for CYP1A2, CYP2A6, CYP2B6, CYP2C9 and CYP3A4 
activity reached quantifiable concentrations albeit with 
considerable inter-donor variability (Fig. 2a). In contrast, 
the concentration of metabolites (mephenytoin, bufuralol 
and chloroxazone) typical for CYP2C19, CYP2D6 and 
CYP2E1 activity remained below the detection limits for 
all donors (data not shown). When cells were grown under 
submerged conditions in KSFM or B/D medium, little or 
no activity was observed for any of the aforementioned 
CYP’s. In general, the concentration of metabolites was 
similar for exposures via the apical and the basal side of the 
3D tissue culture model. Exposure via the basal side was 
selected to measure metabolic activity during differentia-
tion of tissue cultures derived from a single donor (BR265) 
in which metabolites indicative for CYP1A2, CYP2A6, 
CYP2B6, CYP2C9 and CYP3A4 activity were quantified 
(Fig. 2b). For most metabolites, a gradual increase in CYP 
activity was observed with increasing time of air-exposed 
culturing. The only exception was CYP3A4 for which the 
highest activity was measured at the earliest time point. 
The increase in CYP2A6 and CYP2B6 activity was par-
alleled by a significant increase in their gene expression, 
while this was not the case for CYP1A2, CYP2C9 and 
CYP3A4. However, the substrates used to assess activity 
of these CYPs, i.e., phenacetin, diclofenac and midazolam, 
can be metabolized in a similar fashion by, respectively, 
CYP2A6, CYP2C18 and CYP2B6, which all did show 
enhanced expression during ALI-PBEC differentiation. 
All together these findings demonstrate that an increased 
expression of genes involved in xenobiotic metabolism is 
accompanied by an increase, albeit somewhat delayed, in 
enzymatic activity.
Although a wide variety of metabolic genes is expressed 
in mature ALI-PBEC cultures, we were curious how expo-
sure to pulmonary toxicants would affect their expression. 
To this end, we exposed ALI-PBEC cultures to the procar-
cinogens benzo[a]pyrene (BaP) and dibenzo(a,h)anthracene 
(DBA) which are both constituents of gasoline exhaust and 
tobacco smoke. As a control, we investigated the transcrip-
tional response of ALI-PBEC to TCDD, the prototypical 
aryl hydrocarbon receptor (AhR) ligand. Gene expression 
analysis of cultures 24 and 72 h after the start of expo-
sure showed for all three compounds a strong induction 
of CYP1A1 as reported previously (Baxter et al. 2015; 
Newland et al. 2011), while the high basal expression of 
CYP1B1 was further up-regulated (Fig. 3). Consecutively, 
we determined CYP1A1/CYP1B1 activity using a lumino-
genic probe substrate (Luc-CEE) to assess if the enhanced 
expression of CYP1A1 and CYP1B1 following treatment 
with TCDD would lead to an increase in metabolic activ-
ity. For this purpose, we used 23-day-old ALI-PBEC cul-
tures from donor BR234. Indeed, TCDD exposure leads to 
a considerable increase in metabolic activity for CYP1A1/
CYP1B1 (Supplementary Fig. S3A).
As an alternative way to assess the altered metabolic 
activity following TCDD exposure, we exposed mature 
ALI-PBEC cultures, that had or had not been pretreated 
with TCDD, to aflatoxin B1 and determined the effect on 
transepithelial electrical resistance (TEER). Only cultures 
that had been pretreated with TCDD showed a huge impair-
ment in barrier function in line with the ability of CYP1A1 
to bioactivate aflatoxin B1 (Diaz et al. 2010) (Supplemen-
tary Fig. S3B).
Inter‑donor variation and reproducibility
The transcriptional changes of genes involved in xenobi-
otic metabolism during the differentiation procedure were 
in general greater than the variation in expression level 
between donors (Fig. 1). To get more insight into inter-
donor variation in gene expression and into the reproduc-
ibility of ALI-PBEC with regard to the expression of xeno-
biotic metabolism-related genes, three independent studies 
were performed. In each study, two tissue cultures of each 
donor were collected for microarray analysis after 15 days 
of air-exposed culturing. Samples were collected 24 h after 
the last medium change. Applying a linear model on RMA 
condensed data with donor as pairing variable and study as 
confounding factor revealed 276 differentially expressed (q 
value ≤0.05) transcripts corresponding to 190 genes. Unsu-
pervised hierarchical clustering of these genes separated 
the four donors from one another, while within the donors 
duplicates of each study clustered together with the excep-
tion of BR259 study 2 (Supplementary Fig. S4). A heat-
map displaying the expression values of individual genes 
(Fig. 4a) shows that gene expression levels were highly 
reproducible in successive studies. Although many genes 
are differentially expressed between donors, the differences 
in fold changes are generally low. Only 47 of the differen-
tially expressed genes have a FC ≥ 2 between the median 
values of any of the 4 donors (Fig. 4b), and only 6 genes 
display a FC ≥ 5. These genes encode the Phase I enzymes 
AKR1C1, CYP2F1, CYP2Z1 and FMO2, the Phase II 
enzyme GSTT1 and the calcium binding protein S100A12. 
From the 47 genes with donor-specific expression levels 
(FC ≥ 2), 42 (89.4 %) were also among the 143 genes that 
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Fig. 2  Quantification of metab-
olites formed after incubation of 
lung epithelial cells with a cock-
tail of substrates. a Comparison 
of metabolite formation by 
cells derived from four different 
donors grown either under sub-
merged conditions (in KSFM or 
B/D medium) or after differen-
tiation at the air–liquid interface 
for 14 days. The substrate 
cocktail was administered via 
the apical, basal or both sides 
of differentiated tissue cultures. 
Each bar represents the average 
metabolite level of two separate 
cultures. b Metabolite formation 
by cultures from donor BR265 
incubated with the substrate 
cocktail at various days after 
air-exposed culturing. Bars rep-
resent metabolite quantification 
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showed differential expression during the differentiation 
procedure. A remarkable exception is the GSTT1 gene that 
displayed the highest expression difference between donors 
(16.4-fold between donor BR200 and donor BR259) while 
its expression was not influenced by culture conditions or 
differentiation.
Comparison with in vivo data
So far we have demonstrated that in vitro differentiation of 
primary human bronchial epithelial cells leads to a repro-
ducible and largely donor-independent increase in the tran-
scription of genes involved in xenobiotic metabolism. Next, 
we compared our results with the data obtained by LeClerc 
et al. (2011) on xenobiotic metabolism in the lung, includ-
ing bronchial mucosa. In this study, quantitative real-time 
PCR was used for transcriptional profiling of 380 genes 
involved in biotransformation from which 346 (91 %) are 
also present in our analyses. Based on arbitrary cutoffs for 
the median mRNA levels, each gene was categorized as 
being high, moderate, low, very low and non-detectable 
expressed (Fig. 5a). In order to compare the two data sets, 
the median expression levels of the 4 donor cultures were 
ranked and categorized according to the criteria used by 
LeClerc et al. (2011). The results are presented in Fig. 5b. 
From the 346 considered genes, the vast majority 295 
(85.3 %) fell within the same or flanking category (Fig. 5c) 
indicating that gene activity of genes involved in biotrans-
formation in ALI-PBEC to a large extent mimic the in vivo 
situation in the human lung.
Discussion
Despite the fact that inhalation is one of the major exposure 
routes of our body to potentially hazardous substances, 
suitable cell systems to identify harmful effects of airborne 
chemicals have long been lacking (Bakand and Hayes 
2010). However, currently procedures are available that 
allow generation of differentiated ALI-PBEC. ALI-PBEC 
can be brought into continuous dynamic contact with 
chemicals in a test atmosphere simulating in vivo inhala-
tion exposure. Gene expression studies have shown that 
these 3D respiratory epithelial cultures closely resemble 
in vivo airway epithelia (Dvorak et al. 2011; Pezzulo et al. 
2011), while also the enzymatic activity of various CYPs 
Fig. 3  Divisive 2D hierarchical 
clustering with Manhattan as 
distance measure of differen-
tially expressed genes (BH q 
value ≤0.05 and FC ≥ 2) upon 
exposure of 15 days ALI-PBEC 
cultures to 20 µM benzo[a]
pyrene (B[a]P), 125 µM 
dibenzo(a,h)anthracene (DBA) 
or 50 nM 2,3,7,8,-tetrachlorod-
ibenzo-para-dioxin (TCDD) for 
24 or 72 h in comparison with 
time-matched solvent (DMSO) 
controls. The four columns per 
sampling time point represent 
the individual expression values 
for the four donors (from left to 
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such as CYP1A1/1B1 and CYP2A6/2A13 is conserved 
(Baxter et al. 2015; Newland et al. 2011). In the present 
study, we determined the reproducibility and inter-individ-
ual variation of changes in gene activity of genes involved 
in metabolism during the differentiation of primary human 
bronchial epithelial cells into mature ALI-PBEC. In line 
with previous observations (Courcot et al. 2012), expres-
sion levels of genes involved in biotransformation were 
generally low when bronchial epithelial cells were cultured 
submerged. However, expression of many these genes was 
strongly elevated when cells were grown confluent on a tis-
sue culture insert and maintained at the air–liquid interface. 
After about a week of air-exposed culturing, the expression 
levels of genes involved in biotransformation stabilized. 
Gene expression changes were highly reproducible among 
the six biological replicates for each donor, while differ-
ences in fold changes between the four donors were gener-
ally low. Only six genes displayed a FC ≥ 5 between the 
median values of any of the four donors (Fig. 4b).
Various CYPs are highly expressed in ALI-PBEC. 
CYP2B6, CYP2F1, CYP4B1 and CYP4X1 (Fig. 1b) were 
consistently strongly up-regulated in ALI-PBEC (median 
FC > 100), while in contrast CYP1B1 and CYP51A1 were 
already expressed at high levels in undifferentiated lung epi-
thelial cells and only marginally changed expression during 
differentiation. Especially, the highly elevated expression 
Fig. 4  Gene expression levels 
of ALI-PBEC from four donors 
after 15 days of air-exposed 
culturing. a 2D hierarchical 
clustering of 190 genes with 
donor-dependent expression 
levels (BH q value ≤0.05).  
b 2D hierarchical cluster-
ing of the 47 genes that are 
differentially expressed with 
a FC ≥ 2 between any of the 
four donors. Tiles represent the 
median expression levels of 
six independent measurements 
for each donor. Genes with a 
FC ≥ 5 between any of the four 
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of cytochrome P450s CYP2F1 and CYP4B1 in ALI-PBEC 
is of relevance since expression of these CYPs is predomi-
nantly confined to lung tissues with little or no expression in 
other tissues (Pavek and Dvorak 2008; Tournel et al. 2007). 
CYP2F1 is involved in the metabolism of various proto-
typical lung toxicants with potential carcinogenic effects 
such as naphthalene, styrene and 3-methylindole (Carr 
et al. 2003). One of the known substrates of the bioactivat-
ing enzyme CYP4B1 is 4-ipomeanol, a naturally occur-
ring pulmonary protoxin present on moldy sweet potatoes 
(Baer et al. 2005; Choudhary et al. 2005; Parkinson et al. 
2013) that can give rise to interstitial pneumonia in cattle. 
However, human CYP4B1 has been shown to be incapable 
of metabolizing IPO and its physiological function remains 
elusive (Wiek et al. 2015). The other highly expressed 
CYP4 family member CYP4X1 is a so-called orphan 
cytochrome P450 without an assigned biological function 
but also this enzyme is predominantly expressed in human 
trachea and aorta (Savas et al. 2005). Although expression 
of CYP2B6 is not restricted to pulmonary tissue, it prob-
ably plays an important role in cigarette smoke-related 
lung carcinogenesis. CYP2B6 metabolically activates 
tobacco-specific nitrosamines, including the procarcinogen 
4-(methylnitrosamino)-1-(-3-pyridyl)-1-butanone (NNK), 
while genetic variations in CYP2B6 have been suggested as 
a lung cancer risk factor in smokers (Wassenaar et al. 2013). 
CYP1B1 is one of the main extra-hepatic cytochromes and 
is involved in the metabolism of multiple molecules includ-
ing estradiol, retinol, tamoxifen and melatonin (Preissner 
et al. 2010). In humans, it is expressed in many tissues 
including the lung. Transcriptional activity of CYP1B1 is 
like CYP1A1 controlled by the aryl hydrocarbon receptor 
(AhR). Two other CYPs associated with lung cancer risk 
due to cigarette smoking, i.e., CYP2A6 and CYP2A13, dis-
played moderate up-regulation (FC of 9.5 and 8.9, respec-
tively) in differentiated ALI-PBEC.
The two other identified most highly up-regulated Phase 
1 enzymes ADH1C and ALDH1A1 are expressed in most 
human tissues including the lung and are involved in meta-
bolic processing of acetaldehyde during alcohol metabo-
lism. Polymorphisms of ADH1C are associated with the 
risk of upper aerodigestive tract cancer (Oze et al. 2009), 
while ALDH1A1 expression has been found to be down-
regulated in various types of lung cancer (Okudela et al. 
Fig. 5  Comparison of the relative expression levels of 346 genes 
involved in biotransformation between ALI-PBEC cultures and mac-
roscopically healthy bronchial tissue obtained after lung resection 
of lung cancer patients (data from LeClerc et al. (2011)). a Median 
gene expression levels of ALI-PBEC cultures were subdivided into 
five categories (Leclerc et al. 2011) ranging from not detectable to 
highly expressed. b Heatmap displaying attributed category for each 
gene according to our study and LeClerc et al. (2011). The extent of 
difference in attributed category between the two studies is indicated 
with different shades of gray. c Most differentially expressed genes 
between the two studies with difference in expression categories >2
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2013). The gene encoding the Phase II enzyme GSTA1 
was also strongly up-regulated in ALI-PBEC (Supple-
mentary Fig. S2) in line with the reported high expression 
levels in lung tissue (Leclerc et al. 2011), while its expres-
sion was found to be low or non-detectable in primary lung 
cells and lung cell lines, respectively (Courcot et al. 2012). 
Strongly reduced expression levels (FC > 10) in ALI-PBEC 
were found for genes encoding the solute carrier group 
of membrane transport proteins SLC7A5, SLC7A11 and 
SLC22A3. The observed low expression of these family 
7 solute carriers might be related to the differentiated sta-
tus of ALI-PBEC as (Courcot et al. 2012) observed higher 
expression of these genes in lung-derived cell lines and pri-
mary cells than in in vivo lung tissues.
Exposure of mature ALI-PBEC cultures to TCDD, 
the prototypical AhR ligand, and to benzo[a]pyrene and 
dibenz(a,h)anthracene, two aromatic hydrocarbons that 
are both components of tobacco smoke and diesel exhaust, 
resulted in a marked induction of CYP1A1. While the 
induction of CYP1B1 was much more moderate due to its 
already high basal expression in lung epithelial cells, its 
expression level in ALI-PBEC exceeded that of CYP1A1. 
In relation to their ability to metabolize polycyclic aro-
matic hydrocarbons (PAHs), it is important to note that 
in mice CYP1B1 was shown to be the dominant enzyme 
in metabolizing one of the most investigated PAHs, 
7,12-dimethylbenz(a)anthracene (DMBA), to its carcino-
genic metabolites (Buters et al. 2003).
In order to demonstrate that the increase in expression of 
cytochrome P450 enzymes resulted in increased metabolic 
activity, both submerged cultured primary cells and differ-
entiated ALI-PBEC were incubated with a cocktail of sub-
strates. Substrates in this cocktail were not selected to spe-
cifically measure the activity of lung typical P450 enzymes 
but were rather based on the hepatic cytochrome P450 sys-
tem. Nevertheless, even with this suboptimal system we 
could demonstrate that differentiated ALI-PBEC displayed 
substantial metabolic activity. Although the largest increase 
in gene expression occurred during the transition of expo-
nentially growing cells to a confluent layer of cells before 
air exposure, the enzymatic activity showed a more gradual 
increase with time of air-exposed culturing indicating that 
additional changes are required for increased gene expres-
sion of CYP genes to result in enhanced enzymatic activity. 
CYP activity showed the largest increase when after sev-
eral days of air-exposed culturing differentiated cells, such 
as ciliated, goblet and club cells, appeared in the cultures. 
Especially, the latter cell type is reported to possess meta-
bolic capacity. In mice for example, CYP2F2 is primarily 
expressed in the lung by club cells (Ritter et al. 1991) and 
exposure to the CYP2F2 substrate styrene results in club 
cell toxicity, increased proliferation of lung cells and ulti-
mately in the formation of lung tumors. In contrast, rats 
express much lower levels of CYP2F2 and do not develop 
lung tumors upon styrene exposure (Cruzan et al. 2012, 
2013). Expression in humans is restricted to the CYP2F1 
isoform that has a lower catalytic activity than CYP2F2 in 
styrene metabolism, but which displayed a strong up-regu-
lation in differentiated ALI-PBEC. The ability to recognize 
various cell types in ALI-PBEC combined with single-cell 
analysis of potential mutagenic activities (e.g., induction 
of DNA breaks by gamma-H2AX foci formation) of cer-
tain metabolites will enable identification of the cell types 
responsible for the metabolic activation of and sensitivity 
for airborne protoxicants and procarcinogens in humans.
Altogether, our data indicate that differentiated ALI-
PBEC mimic to a large extent in vivo epithelium in terms 
of expression and activity of genes involved in xenobiotic 
and drug metabolic processes. An essential step for their 
application as test vehicles for risk assessment of airborne 
substances is the development of assays able to quantify 
induced (geno)toxicity within the models. With such assays 
in place, ALI-PBEC might aid in elucidating discrepan-
cies in sensitivity between rodents and humans for certain 
inhaled compounds. In addition, these models might be 
used to investigate the effects of various polymorphisms in 
for instance Phase I enzymes that are present in the human 
population on the biotransforming capacities of human 
lung tissue. Other opportunities for ALI-PBEC include the 
possibility to investigate the effect of (geno)toxic exposures 
on the differentiation process, the use of patient-specific 
ALI-PBEC and studies on the effect of pro-inflammatory 
stimuli.
Obviously further validation is required using ALI-
PBEC from larger numbers of well-characterized donors, 
but it is clear that differentiated ALI-PBEC are a use-
ful model to investigate the cellular effects of airborne 
chemicals and have the potential to reduce and eventually 
replace inhalation studies that are currently performed with 
rodents.
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